Novartis AG (NOVN.SW) — Quality & forensics
As of 2026-11-21 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 39
- Quality 82
- Growth 39
- Balance sheet 56
- Cash quality 50
- Capital allocation 74
- Momentum 74
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the NOVN.SW chart & overview
FAQ · from the current data · as of 2026-11-21
Quick answers
What is Novartis AG's Closelooknet quality reading?
The composite reads 58/100 across 7 modules, as of 2026-11-21: valuation 39, quality 82, growth 39, balance sheet 56, cash quality 50, capital allocation 74, momentum 74. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Novartis AG's Altman Z-Score?
3.68, which sits in the safe zone (above 2.99) as of 2026-11-21. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Novartis AG's Piotroski F-Score?
6 of 9, as of 2026-11-21. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Novartis AG's Beneish M-Score indicate?
-2.52 — below the −1.78 manipulation-risk threshold, as of 2026-11-21. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
- HALO Halozyme Therapeutics Incsector
- ONC BeOne Medicines AGsector
- REGN Regeneron Pharmaceuticals Incsector
- UCB.BR UCB SAsector
- ARGX.BR Argen-Xsector
- LLY Eli Lilly and Companysector
- ANN.AU Ansell Ltdsector
- ARGX argenx NV ADRsector
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- ORNAV.HE Orion Oyj Asector
- ORNBV.HE Orion Oyj Bsector
- RIGL Rigel Pharmaceuticals Incsector
- SAN.PA Sanofi SAsector
- DXCM DexCom Incsector
- HQY HealthEquity Incsector
- MEDP Medpace Holdings Incsector
- PTGX Protagonist Therapeutics Incsector
- CEVI.ST CellaVision ABsector
- FPH.AU Fisher & Paykel Healthcare Corporation Ltdsector
- GMED Globus Medicalsector